These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8589283

  • 1. Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity.
    Ellis D, Orchard TJ, Lombardozzi S, Yunis EJ, McCauley J, Agostini R, Diamond JR.
    J Am Soc Nephrol; 1995 Oct; 6(4):1170-7. PubMed ID: 8589283
    [Abstract] [Full Text] [Related]

  • 2. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J, Vilella E.
    Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484
    [Abstract] [Full Text] [Related]

  • 3. Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis.
    Hirano T, Morohoshi T.
    Nephron; 1992 Sep; 60(4):443-7. PubMed ID: 1584321
    [Abstract] [Full Text] [Related]

  • 4. Abnormal lipid metabolism and renal disorders.
    Saito T.
    Tohoku J Exp Med; 1997 Mar; 181(3):321-37. PubMed ID: 9163848
    [Abstract] [Full Text] [Related]

  • 5. Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome.
    Ongkingco JR, Mann WA, Ruley EJ, Gregg RE.
    Child Nephrol Urol; 1991 Mar; 11(2):107-10. PubMed ID: 1756519
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
    Bruschi M, Catarsi P, Candiano G, Rastaldi MP, Musante L, Scolari F, Artero M, Carraro M, Carrea A, Caridi G, Zennaro C, Sanna-Cherchi S, Viola FB, Ferrario F, Perfumo F, Ghiggeri GM.
    Kidney Int; 2003 Feb; 63(2):686-95. PubMed ID: 12631135
    [Abstract] [Full Text] [Related]

  • 7. Focal segmental glomerulosclerosis with and without nephrotic syndrome in children.
    Yoshikawa N, Ito H, Akamatsu R, Matsuyama S, Hasegawa O, Nakahara C, Matsuo T.
    J Pediatr; 1986 Jul; 109(1):65-70. PubMed ID: 3723242
    [Abstract] [Full Text] [Related]

  • 8. Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome.
    Kees-Folts D, Diamond JR.
    Am J Nephrol; 1993 Jul; 13(5):365-75. PubMed ID: 8116689
    [Abstract] [Full Text] [Related]

  • 9. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN.
    Miner Electrolyte Metab; 1993 Jul; 19(3):127-36. PubMed ID: 8232099
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E epsilon 4 allele and nephrotic glomerular diseases in children.
    Asami T, Ciomartan T, Hayakawa H, Uchiyama M, Tomisawa S.
    Pediatr Nephrol; 1999 Apr; 13(3):233-6. PubMed ID: 10353412
    [Abstract] [Full Text] [Related]

  • 11. Focal and segmental glomerular sclerosis in reflux nephropathy.
    Bhathena DB, Weiss JH, Holland NH, McMorrow RG, Curtis JJ, Lucas BA, Luke RG.
    Am J Med; 1980 Jun; 68(6):886-92. PubMed ID: 6992571
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E polymorphism and hyperlipidemia.
    Assmann G, Schmitz G, Menzel HJ, Schulte H.
    Clin Chem; 1984 May; 30(5):641-3. PubMed ID: 6713624
    [Abstract] [Full Text] [Related]

  • 13. Absent pubertal development in a child with chronic renal failure: the case of Frasier syndrome.
    Bönte A, Schröder W, Denamur E, Querfeld U.
    Nephrol Dial Transplant; 2000 Oct; 15(10):1688-90. PubMed ID: 11007843
    [No Abstract] [Full Text] [Related]

  • 14. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

  • 15. Development of renal insufficiency after long-standing steroid-responsive nephrotic syndrome.
    Trainin EB, Gomez-Leon G.
    Int J Pediatr Nephrol; 1982 Jun; 3(2):55-8. PubMed ID: 7107119
    [Abstract] [Full Text] [Related]

  • 16. Progression of minimal-change glomerulopathy to focal glomerulosclerosis in a patient with fenoprofen nephropathy.
    Artinano M, Etheridge WB, Stroehlein KB, Barcenas CG.
    Am J Nephrol; 1986 Jun; 6(5):353-7. PubMed ID: 3826132
    [Abstract] [Full Text] [Related]

  • 17. AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai rat.
    Rodríguez-Iturbe B, Sato T, Quiroz Y, Vaziri ND.
    Kidney Int; 2004 Aug; 66(2):668-75. PubMed ID: 15253721
    [Abstract] [Full Text] [Related]

  • 18. Association of apolipoprotein E gene polymorphism with end-stage renal disease and hyperlipidemia in patients on long-term hemodialysis.
    Lahrach H, Essiarab F, Timinouni M, Hatim B, El Khayat S, Er-Rachdi L, Jarir J, Kettani A, Ghalim N, Taki H, Lebrazi H, Ramdani B, Saïle R.
    Ren Fail; 2014 Nov; 36(10):1504-9. PubMed ID: 25155022
    [Abstract] [Full Text] [Related]

  • 19. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P, Reiner Z, Brunetta B.
    Lijec Vjesn; 2002 Nov; 124(11-12):372-7. PubMed ID: 12679979
    [Abstract] [Full Text] [Related]

  • 20. Renal lesions in sickle cell nephropathy in children.
    Tejani A, Phadke K, Adamson O, Nicastri A, Chen CK, Sen D.
    Nephron; 1985 Nov; 39(4):352-5. PubMed ID: 3982580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.